Activation of cre recombinase alone can induce complete tumor regression

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Li, Yulin ^a   Choi, Peter S ^a   Casey, Stephanie C ^a   Felsher, Dean W ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; TAMOXIFEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; INTEGRASE; PROTEIN P53; UBIQUITIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL POPULATION; CONTROLLED STUDY; ENZYME ACTIVATION; FLOW CYTOMETRY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOMA; LYMPHOMA CELL; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN CLEAVAGE; TUMOR REGRESSION; TUMOR VOLUME; ANIMAL; CARCINOGENESIS; DEFICIENCY; DRUG EFFECTS; GENE THERAPY; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PROMOTER REGION;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; CARCINOGENESIS; ENZYME ACTIVATION; GENETIC THERAPY; INTEGRASES; LYMPHOMA; MAGNETIC RESONANCE IMAGING; MICE; MICE, KNOCKOUT; PROMOTER REGIONS, GENETIC; TAMOXIFEN; TUMOR BURDEN; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN C;

EID: 84947766593     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107589     Document Type: Article

References (12)

1. Gu H, Zou YR, Rajewsky K (1993) Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxPmediated gene targeting. Cell 73: 1155-1164.
2. Rajewsky K, Gu H, Kuhn R, Betz UA, Muller W, et al. (1996) Conditional gene targeting. J Clin Invest 98: 600-603.
3. Loonstra A, Vooijs M, Beverloo HB, Allak BA, van Drunen E, et al. (2001) rowth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc Natl Acad Sci U S A 98: 9209-9214.
4. Pfeifer A, Brandon EP, Kootstra N, Gage FH, Verma IM (2001) Delivery of the Cre recombinase by a self-deleting lentiviral vector: efficient gene targeting in vivo. Proc Natl Acad Sci U S A 98: 11450-11455.
5. Baba Y, Nakano M, Yamada Y, Saito I, Kanegae Y (2005) Practical range of effective dose for Cre recombinase-expressing recombinant adenovirus without cell toxicity in mammalian cells. Microbiol Immunol 49: 559-570.
6. Forni PE, Scuoppo C, Imayoshi I, Taulli R, Dastru W, et al. (2006) High levels of Cre expression in neuronal progenitors cause defects in brain development leading to microencephaly and hydrocephaly. J Neurosci 26: 9593-9602.
7. Bersell K, Choudhury S, Mollova M, Polizzotti BD, Ganapathy B, et al. (2013) Moderate and high amounts of tamoxifen in alphaMHC-MerCreMer mice induce a DNA damage response, leading to heart failure and death. Dis Model Mech 6: 1459-1469.
8. Lexow J, Poggioli T, Sarathchandra P, Santini MP, Rosenthal N (2013) Cardiac fibrosis in mice expressing an inducible myocardial-specific Cre driver. Dis Model Mech 6: 1470-1476.
9. Higashi AY, Ikawa T, Muramatsu M, Economides AN, Niwa A, et al. (2009) Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2. J Immunol 182: 5633-5640.
10. Schmidt-Supprian M, Rajewsky K (2007) Vagaries of conditional gene targeting. Nat Immunol 8: 665-668.
11. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, et al. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221.
12. Ruzankina Y, Pinzon-Guzman C, Asare A, Ong T, Pontano L, et al. (2007) Deletion of the developmentally essential gene ATR in adult mice leads to agerelated phenotypes and stem cell loss. Cell Stem Cell 1: 113-126.